Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Br J Pharmacol ; 165(6): 1827-1835, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21913899

ABSTRACT

BACKGROUND AND PURPOSE: New antithrombotic agents with the potential to prevent atherothrombotic complications are being developed to target receptors on platelets and other cells involved in plaque growth. The aim of this study was to investigate the antiplatelet effects of F 16618, a new non-peptidic PAR1 (thrombin receptor) antagonist. EXPERIMENTAL APPROACH: We investigated the inhibitory effect of F 16618 on human platelet aggregation ex vivo, in whole blood and washed platelets, by using a multiple-electrode platelet aggregometer based on impedance and an optical aggregometer, respectively. Its effects on whole-blood haemostasis (clot parameters) were analysed with the ROTEM thromboelastometry device and the platelet function analyser PFA-100. A guinea-pig model of arterial thrombosis was used to investigate its effects on thrombus formation in vivo. KEY RESULTS: F 16618 inhibited PAR1 agonist peptide (SFLLR-peptide)-induced washed platelet aggregation ex vivo. This effect was concentration-dependent and exhibited a competitive inhibition profile. Washed platelet aggregation, as well as P-selectin expression induced by thrombin, were significantly inhibited by 10 µM F 16618. In whole-blood experiments, 20 µM F 16618 inhibited SFLLR-induced platelet aggregation by 49%. In contrast, it had no effect on whole-blood haemostasis. In the guinea-pig model of carotid thrombosis, 0.32 mg·kg(-1) F 16618 doubled the occlusion time. CONCLUSIONS AND IMPLICATIONS: F 16618 was shown to have strong antithrombotic activity in vivo and moderate antiplatelet effects ex vivo. As these effects were not associated with major effects on physiological haemostasis, this molecule is a good antiplatelet drug candidate for use either alone or in combination with current treatments.


Subject(s)
Fibrinolytic Agents/pharmacology , Piperazines/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation/drug effects , Pyridines/pharmacology , Receptor, PAR-1/antagonists & inhibitors , Animals , Carotid Artery Thrombosis/drug therapy , Collagen/pharmacology , Fibrinolytic Agents/therapeutic use , Guinea Pigs , Hemostasis/drug effects , Humans , Male , Oligopeptides/pharmacology , Piperazines/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Pyridines/therapeutic use , Receptor, PAR-1/agonists , Thrombin/pharmacology
2.
J Eukaryot Microbiol ; Suppl: 50S-55S, 2001.
Article in English | MEDLINE | ID: mdl-11906078

ABSTRACT

We applied a two-dimensional pulsed-field gel electrophoresis procedure to the genomes of two karyotype variants assigned to two different strains of the microsporidian Encephalitozoon cuniculi, termed D (strain III) and F (strain II). Data obtained for BssHII and MluI restriction fragment length polymorphisms in each chromosome are compiled and compared to the reference strain I variant A. Six Insertion/Deletion (InDels) are found in subterminal position, some of these being characteristic of either D or F. Like in strain 1, the terminal fragments extending between each telomere and rDNA locus are conserved in length for each chromosome. They are however smaller than in reference variant. This size reduction is estimated to be 2.5 kbp for the strain III isolate and 3.5 kbp for the strain II isolate. We hypothesize that for the three E. cuniculi strains, all chromosome extremities are prone to a constant process of sequence homogenization through mitotic recombination between conserved regions.


Subject(s)
Encephalitozoon cuniculi/classification , Encephalitozoon cuniculi/genetics , Genetic Variation , Genome, Protozoan , Restriction Mapping/methods , Animals , Bacterial Proteins/metabolism , DNA, Ribosomal/genetics , Deoxyribonucleases, Type II Site-Specific/metabolism , Dogs , Electrophoresis, Gel, Pulsed-Field , Gene Deletion , Karyotyping , Mice , Polymerase Chain Reaction , Recombination, Genetic , Telomere/genetics
3.
Electroencephalogr Clin Neurophysiol ; 86(5): 344-7, 1993 May.
Article in English | MEDLINE | ID: mdl-7685268

ABSTRACT

Evoked magnetic fields to randomized infrequent omissions of visual stimuli resulted in a magnetic field pattern over the right hemisphere consistent with a dipolar source and led to localization of this source within the superior temporal sulcus. Previous investigations using implanted microelectrodes, ablation/lesion procedures in monkeys and observations of behavioral anomalies following injury in humans have already indicated the importance of the inferior portions of the temporal lobe in visual processing. However, until now, no method was available to study noninvasively the role of temporal cortex during visual processing.


Subject(s)
Evoked Potentials, Visual/physiology , Temporal Lobe/physiology , Analysis of Variance , Brain Mapping , Electroencephalography , Electromagnetic Fields , Humans , Magnetic Resonance Imaging , Magnetoencephalography , Photic Stimulation , Temporal Lobe/anatomy & histology
4.
Electroencephalogr Clin Neurophysiol ; 79(4): 308-21, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1717235

ABSTRACT

In this study, two related issues were addressed: first, whether the P3 component of auditory evoked responses, obtained in the context of an oddball paradigm, and its magnetoencephalographically recorded counterpart (P3m) are generated by the same intracranial sources; and, second, whether these sources, modeled as equivalent current dipoles, can be localized in particular brain structures using magnetic resonance imaging. The study involving 8 normal adult subjects resulted in the following findings. (1) Both the similarities and differences in wave form characteristics of the simultaneously recorded P3 and P3m can be best accounted for by common intracranial sources. (2) Several successively activated single-dipolar sources, rather than a single source, account for the entire evolution of the P3m component. (3) Most of these sources were localized in the vicinity of the auditory cortex in all subjects, although some sources appeared to be in deeper structures, possibly the lateral thalamus. (4) The successive activation of sources followed an orderly medial-to-lateral course. These results suggest that activity responsible for the surface-recorded P3 (and P3m) component may be initiated in deep structures, but it quickly spreads over and is sustained in areas near the auditory cortex.


Subject(s)
Brain/physiology , Evoked Potentials, Auditory/physiology , Magnetic Resonance Imaging , Magnetoencephalography , Adult , Algorithms , Brain/pathology , Brain Mapping/methods , Female , Humans , Male , Middle Aged , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL